Literature DB >> 21455201

The origin of neuroendocrine tumors and the neural crest saga.

Juan Rosai1.   

Abstract

In this essay, the role of the neural crest in the development of the vertebrate embryo is briefly described. The techniques used to document the neural crest origin of various cell types and the tumors arising from them are discussed, with emphasis on Le Douarin's quail-chick chimera model. The current dogma on the origin of the cells of the diffuse endocrine system is presented, and some personal conjectures based on the microscopic appearances of various types of normal, vestigial and neoplastic human tissues are offered to the reader as 'food for thought.'

Entities:  

Mesh:

Year:  2011        PMID: 21455201     DOI: 10.1038/modpathol.2010.166

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  29 in total

1.  Origin of Thyroid C Cells: Clinical Interpretation.

Authors:  Stavroula A Paschou; Andromachi Vryonidou
Journal:  Eur Thyroid J       Date:  2016-10-20

Review 2.  Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications.

Authors:  Günter Klöppel
Journal:  Visc Med       Date:  2017-10-16

3.  Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.

Authors:  Laura H Tang; Brian R Untch; Diane L Reidy; Eileen O'Reilly; Deepti Dhall; Lily Jih; Olca Basturk; Peter J Allen; David S Klimstra
Journal:  Clin Cancer Res       Date:  2015-10-19       Impact factor: 12.531

Review 4.  Neuroendocrine tumors of extrahepatic biliary tract.

Authors:  Nickos Michalopoulos; Theodossis S Papavramidis; Georgia Karayannopoulou; Ioannis Pliakos; Spiros T Papavramidis; Ioannis Kanellos
Journal:  Pathol Oncol Res       Date:  2014-06-11       Impact factor: 3.201

Review 5.  Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?

Authors:  Michael S Lee; Bert H O'Neil
Journal:  J Gastrointest Oncol       Date:  2016-10

6.  A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.

Authors:  Mariano J Alvarez; Prem S Subramaniam; Laura H Tang; Adina Grunn; Mahalaxmi Aburi; Gabrielle Rieckhof; Elena V Komissarova; Elizabeth A Hagan; Lisa Bodei; Paul A Clemons; Filemon S Dela Cruz; Deepti Dhall; Daniel Diolaiti; Douglas A Fraker; Afshin Ghavami; Daniel Kaemmerer; Charles Karan; Mark Kidd; Kyoung M Kim; Hee C Kim; Lakshmi P Kunju; Ülo Langel; Zhong Li; Jeeyun Lee; Hai Li; Virginia LiVolsi; Roswitha Pfragner; Allison R Rainey; Ronald B Realubit; Helen Remotti; Jakob Regberg; Robert Roses; Anil Rustgi; Antonia R Sepulveda; Stefano Serra; Chanjuan Shi; Xiaopu Yuan; Massimo Barberis; Roberto Bergamaschi; Arul M Chinnaiyan; Tony Detre; Shereen Ezzat; Andrea Frilling; Merten Hommann; Dirk Jaeger; Michelle K Kim; Beatrice S Knudsen; Andrew L Kung; Emer Leahy; David C Metz; Jeffrey W Milsom; Young S Park; Diane Reidy-Lagunes; Stuart Schreiber; Kay Washington; Bertram Wiedenmann; Irvin Modlin; Andrea Califano
Journal:  Nat Genet       Date:  2018-06-18       Impact factor: 38.330

7.  Biology and evolution of poorly differentiated neuroendocrine tumors.

Authors:  David S Rickman; Himisha Beltran; Francesca Demichelis; Mark A Rubin
Journal:  Nat Med       Date:  2017-06-06       Impact factor: 53.440

Review 8.  Peptide Receptor Radionuclide Therapy in Thyroid Cancer.

Authors:  Sriram Gubbi; Christian A Koch; Joanna Klubo-Gwiezdzinska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-30       Impact factor: 6.055

Review 9.  Small-cell lung cancer: what we know, what we need to know and the path forward.

Authors:  Adi F Gazdar; Paul A Bunn; John D Minna
Journal:  Nat Rev Cancer       Date:  2017-10-27       Impact factor: 60.716

10.  Genetics and molecular pathology of gastric malignancy: Development of targeted therapies in the era of personalized medicine.

Authors:  Michael Van Ness; Jeffrey Gregg; Jun Wang; Mingyi Chen
Journal:  J Gastrointest Oncol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.